The effect of ionic strength on melting of DNA modified by platinum(II) complexes

Biophysical Chemistry

Volumn 60, Issue 3, 1996, Pages 135-142

  Žaludová, Renata ^a   Kleinwächter, Vladimír ^a   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

DNA modification; DNA stability; DNA thermal denaturation; Platinum antitumor complexes; Structure activity relationship

Indexed keywords

CISPLATIN; PLATINUM DERIVATIVE; TRANSPLATIN;

ARTICLE; DNA BINDING; PRIORITY JOURNAL; THERMAL ANALYSIS;

EID: 0030579809     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-4622(96)00010-5     Document Type: Article

References (24)

1. [1] J. Drobník, Cancer Chemother. Pharmacol., 10 (1983) 145.
2. [2] P.J. Loehrer and L.H. Einhorn, Ann. Intern. Med., 100 (1984) 704.
3. [3] J. Reedijk, Pure Appl. Chem., 59 (1987) 181.
4. [4] N.P. Johnson, J.L. Butour, G. Villani, F.L. Wimmer, M. Defais, V. Pierson and V. Brabec, Prog. Clin. Biochem. Med., 10 (1989) 1.
5. [5] C.A. Lepre and S.J. Lippard, Nucleic Acids Molec. Biol., 4 (1990) 3.
6. [6] M. Leng and V. Brabec, in K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar, D. Segerbäck and H. Bartsch (Editors), DNA Adducts of Cisplatin, Transplatin and Platinum-Intercalating Drugs (DNA Adducts: Identification and Biological Significance, IARC Scientific Publications No. 125), International Agency for Research on Cancer, Lyon, 1994, p. 339.
7. [7] P.D. Bancroft, C.A. Lepre and S.J. Lippard, J. Am. Chem. Soc., 112 (1990) 6860.
8. [8] A. Eastman, Pharmacol. Ther., 34 (1987) 155.
9. [9] V. Brabec, V. Kleinwächter, J.L. Butour and N.P. Johnson, Biophys. Chem., 35 (1990) 129.
10. [10] N.P. Johnson, J.P. Macquet, J.L. Wiebers and B. Monsarrat, Nucleic Acids Res., 10 (1982) 5255.
11. [11] V. Brabec, J. Reedijk and M. Leng, Biochemistry, 31 (1992) 12397.
12. [12] C.J. van Garderen, H. van den Elst, J.H. van Boom and J. Reedijk, J. Am. Chem. Soc., 111 (1989) 4123.
13. [13] O. Vrána, V. Brabec and V. Kleinwächter, Anti-Cancer Drug Des., 1 (1986) 95.
14. [14] V. Brabec and E. Paleček, Biophys. Chem., 4 (1976) 79.
15. [15] M.A. Lemaire, A. Schwartz, R.A. Rahmouni and M. Leng, Proc. Natl. Acad. Sci. USA, 88 (1991) 1982.
16. [16] S.D. Kim, O. Vrána, V. Kleinwächter, K. Niki and V. Brabec, Anal. Lett., 23 (1990) 1505.
17. [17] V. Brabec, V. Boudný and Z. Balcarová, Biochemistry, 33 (1994) 1316.
18. [18] C.L. Schildkraut and S. Lifson, Biopolymers, 3 (1965) 195.
19. [19] J. Chambron, M. Daune and Ch. Sadron, Biochim. Biophys. Acta, 123 (1966) 319.
20. [20] D.O. Jordan, The Chemistry of the Nucleic Acids, Butterworths, London, 1960, p. 216.
21. [21] V. Kleinwächter, Z. Balcarová and J. Boháček, Biochim. Biophys. Acta, 174 (1969) 188.
22. [22] Yu.M. Evdokimov and Ya.M. Varshavskii, Biofizika, 11 (1966) 7.
23. [23] J.M. Malinge, C. Pérez and M. Leng, Nucleic Acids Res., 22 (1994) 3834.
24. [24] V. Brabec and M. Leng, Proc. Natl. Acad. Sci. USA, 90 (1993) 5345.